Clinical utility of non-ceruloplasmin copper determined by copper speciation for monitoring Wilson disease therapy: comparative data analysis with 24-hour urinary copper excretion from the CHELATE trial

Category Primary study
JournalJournal of Hepatology
Year 2022
This article has no abstract
Epistemonikos ID: f87801586e603b3a34219326a30960c438de71c4
First added on: Feb 14, 2025